SKIN PATCH TEST FOR THE DIAGNOSIS OF IMMUNOLOGICAL PROTECTION AGAINST SARS-COV-2 VIRUS INFECTION
The invention relates to the application of a skin patch test for the detection of the specific cellular immune response against the SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2). The skin patch contains a formulated version of the recombinant form of SARS-CoV-2 antigenic protein. The...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
05.07.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to the application of a skin patch test for the detection of the specific cellular immune response against the SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2). The skin patch contains a formulated version of the recombinant form of SARS-CoV-2 antigenic protein. The application of the skin patch allows to follow the local skin reaction reflecting the strength of the cellular immune reaction against SARS-CoV-2, thus the skin test is applicable to a diagnostic evaluation of the specific cellular immunity evoked by previous virus infection or by vaccination against COVID-19. |
---|---|
Bibliography: | Application Number: EP20210805596 |